CERVICAL CARCINOMA
Clinical trials for CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Decade-Long study tracks HPV Vaccine's lasting power against cancer
⭐️ VACCINE ⭐️ OngoingThis study is tracking thousands of young women in Costa Rica for 10 years to see how well the HPV vaccine protects against cervical cancer over the long term. It compares women who received the vaccine years ago with a new group of unvaccinated women. The goal is to understand t…
Matched conditions: CERVICAL CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 24, 2026 12:02 UTC
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial targets Tough-to-Treat rare cancers
Disease control TerminatedThis study is testing an experimental drug called XmAb20717 in adults with advanced rare cancers that have few treatment options. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. The trial is currently suspended and is not enrolling …
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for cervical cancer patients when standard immunotherapy stops working
Disease control OngoingThis study is testing whether a combination of two drugs, zimberelimab and lenvatinib, can help control advanced cervical cancer that has continued to grow despite prior immunotherapy. It aims to see if this combination is safe and effective for up to 30 women whose cancer has pr…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Could a simple At-Home swab replace the Doctor's visit for cervical cancer screening?
Diagnosis OngoingThis study is testing whether a vaginal sample you collect yourself at home is as good at finding the HPV virus as a sample a doctor collects during a pelvic exam. It involves 520 women who are already scheduled for a follow-up cervical exam. The goal is to make cervical cancer s…
Matched conditions: CERVICAL CARCINOMA
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Mar 02, 2026 15:23 UTC
-
At-Home cervical cancer screening test could save lives
Diagnosis OngoingThis study is testing whether people can collect their own vaginal samples for HPV testing as accurately as a doctor can collect cervical samples during a pelvic exam. The goal is to make cervical cancer screening more accessible and comfortable, especially for those who avoid cl…
Matched conditions: CERVICAL CARCINOMA
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Feb 23, 2026 14:57 UTC
-
Home test kits aim to catch more cervical cancer early
Prevention ENROLLING_BY_INVITATIONThis study is testing whether offering easy-to-use, at-home HPV swab kits at walk-in clinics with evening and weekend hours can help more women get screened for cervical cancer. It will involve 500 women aged 30-63 who are overdue for their regular screening. Researchers will com…
Matched conditions: CERVICAL CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Mar 24, 2026 12:01 UTC
-
Could a simple At-Home swab replace the Doctor's office for cervical cancer screening?
Prevention OngoingThis study is testing whether people can collect their own vaginal samples at home for HPV testing as accurately as a doctor collects samples in a clinic. It involves 500 people who have already been referred for a follow-up cervical exam. The goal is to make cervical cancer scre…
Matched conditions: CERVICAL CARCINOMA
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Mar 13, 2026 15:05 UTC
-
Tracking life after radical cancer surgery
Knowledge-focused OngoingThis study aims to understand the recovery process for women who have a major surgery called pelvic exenteration to treat gynecologic cancers. Researchers are observing 79 women to see which surgical techniques lead to fewer complications and better long-term quality of life. The…
Matched conditions: CERVICAL CARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test new 'Tumor Glow' scan for Hard-to-Spot cancers
Knowledge-focused OngoingThis early-stage study is testing a new imaging agent called 68Ga-FAPI-46 to see where it goes in the body of patients with many different types of cancer. The goal is to understand if this tracer can help doctors better see and understand tumors by highlighting specific cells ar…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC